Therapy Glow

Therapy Glow Disclaimer: This content is for educational purposes only and does not constitute psychotherapy, diagnosis, or medical advice.
(1)

Ari Leal, RMHCI (FL) under qualified supervision. If you are experiencing a mental health emergency, contact 911 or 988.

Not every PTSD symptom is a memory problem. Sometimes the nervous system is overfitted to threat. The Amyg-EFP-NF analys...
07/22/2026

Not every PTSD symptom is a memory problem. Sometimes the nervous system is overfitted to threat. The Amyg-EFP-NF analysis points to a more personalized path: individualized neurofeedback tied to amygdala biomarkers, with reductions across hypervigilance, threat detection, and broader symptom clusters. The clinical takeaway is simple: precision matters. If the goal is durable change, we have to work with the brain’s prediction system—not just the story a client tells about it.

That doesn’t replace psychotherapy. It can widen the window in which therapy becomes usable.

(Source: FDA-cleared Amyg-EFP-NF combined analysis of three clinical trials, 2026) Learn more at therapyglow.com

FDA has authorized a first-of-its-kind neuromodulation device for PTSD symptoms.What interests me clinically is not the ...
07/21/2026

FDA has authorized a first-of-its-kind neuromodulation device for PTSD symptoms.

What interests me clinically is not the device itself, but the implication: some people may need support at the level of physiology before insight can land. For high-insight adults, that distinction matters. You can understand your patterns perfectly and still have a nervous system that behaves as if danger is present.

This is where I stay sober: devices are not substitutes for trauma therapy, attachment work, or careful screening. But as adjuncts, they may expand what becomes possible between sessions—especially for clients who need more capacity before deeper processing.

(Source: FDA de novo approval, Neurovalens' Modius Spero, May 2026)



Learn more at therapyglow.com

PTSD is often lived as a body-level state of alertness, not just a story about the past. So I pay attention when non-inv...
07/21/2026

PTSD is often lived as a body-level state of alertness, not just a story about the past. So I pay attention when non-invasive tools begin to show up as real adjuncts in care.

Neurovalens’ Modius Spero received FDA de novo authorization for PTSD symptoms, adding another option for people who need support beyond talk alone. The clinical point is not “device over therapy.” It’s access to a calmer baseline, alongside pacing, assessment, and integration.

(Source: FDA de novo approval, Neurovalens' Modius Spero, 2026). Learn more at therapyglow.com

When trauma keeps the body on alert, precision matters.
07/20/2026

When trauma keeps the body on alert, precision matters.

Chronic pain is not just a tissue problem. In the University of New South Wales “Pain and Emotion Therapy” clinical tria...
07/20/2026

Chronic pain is not just a tissue problem. In the University of New South Wales “Pain and Emotion Therapy” clinical trial, emotion regulation training was associated with pain reduction and better daily functioning.

That matters because chronic pain often outlives the original injury. The nervous system can keep sounding the alarm long after tissue repair is no longer the full story. Regulation work doesn’t “make pain up.” It helps change the brain-body prediction loop that keeps pain stuck.

For high-insight adults, this is a useful reframe: relief is often not about pushing harder, but about helping the system feel safe enough to update.

(Source: University of New South Wales “Pain and Emotion Therapy” clinical trial, 2025-2026)



Learn more at therapyglow.com

Psilocybin is moving closer to a regulated treatment pathway for treatment-resistant depression. The part that matters c...
07/20/2026

Psilocybin is moving closer to a regulated treatment pathway for treatment-resistant depression. The part that matters clinically is not the headline; it's the work around screening, preparation, and integration.

If this reaches approval, the standard of care will need to be more than a substance. It will need structure, discernment, and aftercare.

(Source: COMPASS Pathways Phase 3 Trials (COMP005 & COMP006), 2026)

Learn more at therapyglow.com

Emotion regulation is not just insight; it is access under load.A new trial pairing emotion-regulation skills with dlPFC...
07/19/2026

Emotion regulation is not just insight; it is access under load.

A new trial pairing emotion-regulation skills with dlPFC-targeted rTMS asks a clinically important question: can neuromodulation make regulation easier to learn and easier to use when stress rises? If this holds, the value is scaffolding — not shortcutting — therapy.

For high-insight adults, this matters. Knowing why you react is different from having the nervous system capacity to respond differently.

(Source: Clinical trial, May 2026 (targeting dlPFC with repetitive TMS), 2026)

Learn more at therapyglow.com

When trauma lives in the threat system, insight alone can hit a ceiling.A new combined analysis of Amyg-EFP-NF suggests ...
07/19/2026

When trauma lives in the threat system, insight alone can hit a ceiling.

A new combined analysis of Amyg-EFP-NF suggests precision neurofeedback may reduce PTSD symptom clusters by training individualized amygdala-based markers of threat detection. That matters clinically because many high-insight adults do not need more explanation

New signal from the VA: a randomized trial is testing MDMA-assisted therapy for veterans with severe PTSD and alcohol us...
07/19/2026

New signal from the VA: a randomized trial is testing MDMA-assisted therapy for veterans with severe PTSD and alcohol use disorder. The important part is not the molecule alone; it's the model of care around it — careful screening, therapeutic containment, and integration after the session. Trauma treatment works when we respect complexity instead of flattening it. (Source: U.S. Department of Veterans Affairs, 2026) Learn more at therapyglow.com

Emotion regulation is not just a coping slogan. In early trials, pairing emotion-regulation skills with rTMS over the do...
07/18/2026

Emotion regulation is not just a coping slogan. In early trials, pairing emotion-regulation skills with rTMS over the dorsolateral prefrontal cortex is asking a sharper question: can we help the nervous system learn regulation while the brain is more plastic?

That matters for people who know what helps them, but lose access to it when stress hits.

(Source: Clinical trial, May 2026 (targeting dlPFC with repetitive TMS))



Learn more at therapyglow.com

Address

Saint Petersburg, FL

Opening Hours

Monday 8am - 8pm
Tuesday 8am - 8pm
Wednesday 8am - 8pm
Friday 8am - 8pm

Telephone

+17277171100

Website

Alerts

Be the first to know and let us send you an email when Therapy Glow posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Therapy Glow:

Shortcuts

Share

Category